-transparent.png){kind=logo}
The mechanisms by which platelet-activating factor (PAF) and thrombin increase intracellular calcium were examined. Platelets were loaded with the calcium-sensitive fluorescent probe Quin 2 and then were suspended in buffer containing 0.5 mM-Mn2+ in order to quantify simultaneously calcium release from intracellular stores and divalent cation influx. Pretreating platelets with agents which activate protein kinase C [the phorbol ester phorbol myristate acetate (PMA) or the diacylglycerol 1-oleoyl-2-acetylglycerol (OAG)] inhibited increased intracellular calcium by PAF and thrombin in a dose-related manner. That protein kinase C regulates intracellular calcium by phosphorylating proteins in two distinct pathways was suggested by two observations. PAF-induced calcium release was more sensitive to inhibition by PMA and OAG than was manganese influx and the kinetics of recovery from inhibition were different for the two pathways. Both PMA and OAG aggregated Quin 2-loaded platelets without eliciting measurable increases in intracellular calcium. In contrast, prostacyclin, which increases intracellular cyclic AMP, inhibited calcium release and influx in parallel, suggesting that this agent acts at a step common to both pathways.
F H Valone, and
B Johnson
March 1994,
The American journal of physiology,
F H Valone, and
B Johnson
August 1986,
Biochemical and biophysical research communications,
F H Valone, and
B Johnson
April 1995,
Journal of cell science,
F H Valone, and
B Johnson
November 1988,
European journal of biochemistry,
F H Valone, and
B Johnson
April 1989,
The American review of respiratory disease,
F H Valone, and
B Johnson
June 1989,
FEBS letters,
F H Valone, and
B Johnson
March 1994,
Arerugi = [Allergy],
F H Valone, and
B Johnson
June 1983,
Thrombosis and haemostasis,
F H Valone, and
B Johnson
January 1989,
Arteriosclerosis (Dallas, Tex.),
F H Valone, and
B Johnson
October 1981,
Biochemical and biophysical research communications,
